A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC)
Crossref DOI link: https://doi.org/10.1007/s00280-015-2876-7
Published Online: 2015-10-03
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mizugaki, Hidenori
Yamamoto, Noboru
Nokihara, Hiroshi
Fujiwara, Yutaka
Horinouchi, Hidehito
Kanda, Shintaro
Kitazono, Satoru
Yagishita, Shigehiro
Xiong, Hao
Qian, Jane
Hashiba, Hideyuki
Shepherd, Stacie P.
Giranda, Vincent
Tamura, Tomohide
License valid from 2015-10-03